Giedrė Balčiūnaitė
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Giedrė Balčiūnaitė has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Darius Palionis
Vilnius University
8 shared publicationsPeter Sogaard
Aalborg University
7 shared publicationsAudrius Aidietis
Vilnius University: Vilniaus Universitetas, Vilnius, Lithuania
6 shared publicationsTomas Zaremba
Vilnius University: Vilniaus Universitetas, Vilnius, Lithuania
6 shared publicationsAleksejus Zorinas
Vilnius University
5 shared publicationsViktor Skorniakov
Vilnius University: Vilniaus Universitetas, Vilnius, Lithuania
5 shared publications
Latest Publications
- Open Access
Artificial Intelligence Performance in Cardiac Magnetic Resonance Strain Analysis for Aortic Stenosis: Validation with Echocardiography and Healthy Controls
Background and Objectives: Aortic stenosis (AS) leads to progressive left ventricular (LV) dysfunction, making early detection crucial. Global longitudinal strain (GLS) is an echocardiographic marker of subclinical LV dysfunction; however, echocardiography has limitations, including operator dependency and acoustic variability. Cardiac magnetic resonance (CMR) is a valuable complementary tool, and artificial intelligence (AI) may enhance strain measurement accuracy, though its role in AS remains underexplored. To evaluate the performance of an AI-based CMR feature tracking tool for the assessment of LV global and segmental GLS in AS patients and compare results with the respective measurements from healthy volunteers (control group), as well as with the GLS obtained using the echocardiographic speckle tracking technique. Materials and Methods: This retrospective study analysed 111 CMR exams (70 AS patients, 41 healthy controls) from a single centre. AI-derived GLS values from gradient echo 2-, 3-, and 4-chamber CMR views were manually reviewed for accuracy. Error rates, segmental, and global myocardial strain differences were assessed between AS patients and the control group. Results: AI-based CMR GLS strongly correlated with echocardiographic GLS (r = 0.694, p < 0.001) and showed lower variability. The AI-derived GLS from CMR was significantly lower in aortic stenosis patients compared to controls (−17.86 ± 3.47 vs. −20.70 ± 1.98). However, AI-based strain analysis had an overall error rate of 6%, which was significantly higher in AS patients (18.6%) compared to healthy controls (2.44%) (p = 0.0088). The 3-chamber CMR view was the most error-prone (50% of isolated errors). Segmental strain variability between AS patients and controls was most pronounced in basal segments, with smaller differences in middle and apical segments. CMR demonstrated greater precision than echocardiography, as indicated by a smaller standard deviation in GLS measurements (3.47 vs. 4.98). Conclusions: The AI-based CMR feature tracking technique provides accurate and reproducible GLS measurements, showing strong agreement with echocardiographic speckle tracking-based GLS. However, the higher error rates in AS patients compared to controls underscore the need for more advanced AI algorithms to improve performance in cardiac pathology.
Open AccessArtificial Intelligence Performance in Cardiac Magnetic Resonance Strain Analysis for Aortic Stenosis: Validation with Echocardiography and Healthy Controls
Background and Objectives: Aortic stenosis (AS) leads to progressive left ventricular (LV) dysfunction, making early detection crucial. Global longitudinal strain (GLS) is an echocardiographic marker of subclinical LV dysfunction; however, echocardiography has limitations, including operator dependency and acoustic variability. Cardiac magnetic resonance (CMR) is a valuable complementary tool, and artificial intelligence (AI) may enhance strain measurement accuracy, though its role in AS remains underexplored. To evaluate the performance of an AI-based CMR feature tracking tool for the assessment of LV global and segmental GLS in AS patients and compare results with the respective measurements from healthy volunteers (control group), as well as with the GLS obtained using the echocardiographic speckle tracking technique. Materials and Methods: This retrospective study analysed 111 CMR exams (70 AS patients, 41 healthy controls) from a single centre. AI-derived GLS values from gradient echo 2-, 3-, and 4-chamber CMR views were manually reviewed for accuracy. Error rates, segmental, and global myocardial strain differences were assessed between AS patients and the control group. Results: AI-based CMR GLS strongly correlated with echocardiographic GLS (r = 0.694, p < 0.001) and showed lower variability. The AI-derived GLS from CMR was significantly lower in aortic stenosis patients compared to controls (−17.86 ± 3.47 vs. −20.70 ± 1.98). However, AI-based strain analysis had an overall error rate of 6%, which was significantly higher in AS patients (18.6%) compared to healthy controls (2.44%) (p = 0.0088). The 3-chamber CMR view was the most error-prone (50% of isolated errors). Segmental strain variability between AS patients and controls was most pronounced in basal segments, with smaller differences in middle and apical segments. CMR demonstrated greater precision than echocardiography, as indicated by a smaller standard deviation in GLS measurements (3.47 vs. 4.98). Conclusions: The AI-based CMR feature tracking technique provides accurate and reproducible GLS measurements, showing strong agreement with echocardiographic speckle tracking-based GLS. However, the higher error rates in AS patients compared to controls underscore the need for more advanced AI algorithms to improve performance in cardiac pathology.
- Open Access
- 1 July 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (7) , 707
The Relative Apical Sparing Strain Pattern in Severe Aortic Valve Stenosis: A Marker of Adverse Cardiac Remodeling
Background: The presence of a relative apical sparing (RAS) echocardiographic strain pattern raises a suspicion of underlying cardiac amyloidosis (CA). However, it is also increasingly observed in patients with aortic stenosis (AS). We aimed to evaluate the prevalence, dynamics, and clinical characteristics of the RAS strain pattern in severe AS patients who had been referred for surgical aortic valve replacement (SAVR). Methods: A total of 77 patients with severe AS and without CA were included with a mean age of 70 (62–73) years, 58% female, a mean aortic valve area index of 0.45 ± 0.1 cm2/m2, and a mean gradient of 54.9 (45–70) mmHg. Results: An RAS strain pattern was detected in 14 (18%) patients. RAS-positive patients had a significantly higher LV mass index (125 ± 28 g/m2 vs. 91 ± 32, p = 0.001), a lower LV ejection fraction (62 ± 12 vs. 68 ± 13, p = 0.040), and lower global longitudinal strain (–14.9 ± 3 vs. –18.7 ± 5%, p = 0.002). RAS strain pattern-positive patients also had higher B-type natriuretic peptide (409 (161–961) vs. 119 (66–245) pg/L, p = 0.032) and high-sensitivity troponin I (15 (13–29) vs. 9 (5–18) pg/L, p = 0.026) levels. Detection of an RAS strain pattern was strongly associated with increased LV mass index (OR 1.03, 95% CI 1.01–1.06, p < 0.001). The RAS strain pattern had resolved in all patients by 3 months after SAVR. Conclusions: Our findings suggest that the RAS strain pattern can be present in patients with severe AS without evidence of CA. The presence of an RAS strain pattern is associated with adverse LV remodeling, and it resolves after SAVR.
- 1 July 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (7) , 707
Open AccessThe Relative Apical Sparing Strain Pattern in Severe Aortic Valve Stenosis: A Marker of Adverse Cardiac Remodeling
Background: The presence of a relative apical sparing (RAS) echocardiographic strain pattern raises a suspicion of underlying cardiac amyloidosis (CA). However, it is also increasingly observed in patients with aortic stenosis (AS). We aimed to evaluate the prevalence, dynamics, and clinical characteristics of the RAS strain pattern in severe AS patients who had been referred for surgical aortic valve replacement (SAVR). Methods: A total of 77 patients with severe AS and without CA were included with a mean age of 70 (62–73) years, 58% female, a mean aortic valve area index of 0.45 ± 0.1 cm2/m2, and a mean gradient of 54.9 (45–70) mmHg. Results: An RAS strain pattern was detected in 14 (18%) patients. RAS-positive patients had a significantly higher LV mass index (125 ± 28 g/m2 vs. 91 ± 32, p = 0.001), a lower LV ejection fraction (62 ± 12 vs. 68 ± 13, p = 0.040), and lower global longitudinal strain (–14.9 ± 3 vs. –18.7 ± 5%, p = 0.002). RAS strain pattern-positive patients also had higher B-type natriuretic peptide (409 (161–961) vs. 119 (66–245) pg/L, p = 0.032) and high-sensitivity troponin I (15 (13–29) vs. 9 (5–18) pg/L, p = 0.026) levels. Detection of an RAS strain pattern was strongly associated with increased LV mass index (OR 1.03, 95% CI 1.01–1.06, p < 0.001). The RAS strain pattern had resolved in all patients by 3 months after SAVR. Conclusions: Our findings suggest that the RAS strain pattern can be present in patients with severe AS without evidence of CA. The presence of an RAS strain pattern is associated with adverse LV remodeling, and it resolves after SAVR.
- Open Access
- 27 August 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (17) , 5588
Electrocardiographic Markers of Adverse Left Ventricular Remodeling and Myocardial Fibrosis in Severe Aortic Stenosis
The optimal timing for aortic valve replacement (AVR) in aortic stenosis (AS) is still controversial and may be guided by markers of adverse left ventricular (LV) remodeling. We aim to assess electrocardiographic (ECG) strain in relation to LV remodeling and myocardial fibrosis. 83 severe AS patients underwent surgical AVR, with preoperative 12-lead ECG, cardiovascular magnetic resonance with T1 mapping and echocardiography with global longitudinal strain analysis. Collagen volume fraction (CVF) was measured in myocardial biopsies sampled during AVR. Patients with ECG strain had more severe AS, more advanced LV remodeling and evidence of heart failure. Patients with ECG strain had more diffuse fibrosis, as evident by higher mean native T1 values (974.8 ± 34 ms vs. 946.5 ± 28 ms, p < 0.001). ECG strain was the only predictor of increased LV mass index on multivariate regression analysis (OR = 7.10, 95% CI 1.46–34.48, p = 0.02). Patients with persistent ECG strain at 1 year following AVR had more advanced LV remodeling and more histological fibrosis (CVF 12.5% vs. 7.3%, p = 0.009) at baseline assessment. Therefore, ECG strain is a marker of adverse LV remodeling and interstitial myocardial fibrosis. Lack of improvement in ECG strain following AVR indicates more advanced baseline LV injury and higher levels of myocardial fibrosis.
- 27 August 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (17) , 5588
Open AccessElectrocardiographic Markers of Adverse Left Ventricular Remodeling and Myocardial Fibrosis in Severe Aortic Stenosis
The optimal timing for aortic valve replacement (AVR) in aortic stenosis (AS) is still controversial and may be guided by markers of adverse left ventricular (LV) remodeling. We aim to assess electrocardiographic (ECG) strain in relation to LV remodeling and myocardial fibrosis. 83 severe AS patients underwent surgical AVR, with preoperative 12-lead ECG, cardiovascular magnetic resonance with T1 mapping and echocardiography with global longitudinal strain analysis. Collagen volume fraction (CVF) was measured in myocardial biopsies sampled during AVR. Patients with ECG strain had more severe AS, more advanced LV remodeling and evidence of heart failure. Patients with ECG strain had more diffuse fibrosis, as evident by higher mean native T1 values (974.8 ± 34 ms vs. 946.5 ± 28 ms, p < 0.001). ECG strain was the only predictor of increased LV mass index on multivariate regression analysis (OR = 7.10, 95% CI 1.46–34.48, p = 0.02). Patients with persistent ECG strain at 1 year following AVR had more advanced LV remodeling and more histological fibrosis (CVF 12.5% vs. 7.3%, p = 0.009) at baseline assessment. Therefore, ECG strain is a marker of adverse LV remodeling and interstitial myocardial fibrosis. Lack of improvement in ECG strain following AVR indicates more advanced baseline LV injury and higher levels of myocardial fibrosis.
- Open Access
- 16 March 2023
- Published by Springer Nature in Research Square
Electrocardiographic markers of adverse left ventricular remodeling and myocardial fibrosis in severe aortic stenosis
Background. The optimal timing for aortic valve replacement (AVR) in aortic stenosis (AS) is still controversial and may be guided by markers of adverse left ventricular (LV) remodeling. We aim to assess electrocardiographic (ECG) strain patterns in relation to adverse LV remodeling and myocardial fibrosis. Methods. A total of 83 symptomatic severe AS patients (age 66.5 ± 8.6, 42% male) scheduled for surgical AVR underwent preoperative cardiovascular magnetic resonance (CMR) with T1 mapping and echocardiography with global longitudinal strain (GLS) analysis. Collagen volume fraction (CVF) was measured in myocardial biopsies (71) sampled at the time of AVR. The 12-lead ECG was performed preoperatively and 3 and 12 months postoperatively. Results. ECG strain-positive patients (prevalence of 43.4%) had more severe AS, increased LV mass, higher levels of brain natriuretic peptides (BNP) and high-sensitivity troponin I, lower GLS, and lower LV ejection fraction (LVEF). Patients with ECG strain had more diffuse fibrosis, as evident by higher native T1 values (974.8 ± 33.6 ms vs 946.5 ± 28.2 ms, p < 0.001). ECG strain was the only predictor of increased LV mass index on multivariate regression analysis (OR = 7.10, 95% CI 1.46–34.48, p = 0.015). Patients with persistent ECG strain at 1 year following AVR had larger LV volumes and mass, lower GLS, lower LVEF, higher BNP levels, and more histological fibrosis (CVF 12.5% vs. 7.3%, p = 0.009) at baseline assessment. Conclusion. ECG strain is a marker of adverse structural and functional LV remodeling and interstitial myocardial fibrosis. Lack of improvement in ECG strain following AVR indicates more advanced baseline LV injury and higher levels of myocardial fibrosis.
- 16 March 2023
- Published by Springer Nature in Research Square
Open AccessElectrocardiographic markers of adverse left ventricular remodeling and myocardial fibrosis in severe aortic stenosis
Background. The optimal timing for aortic valve replacement (AVR) in aortic stenosis (AS) is still controversial and may be guided by markers of adverse left ventricular (LV) remodeling. We aim to assess electrocardiographic (ECG) strain patterns in relation to adverse LV remodeling and myocardial fibrosis. Methods. A total of 83 symptomatic severe AS patients (age 66.5 ± 8.6, 42% male) scheduled for surgical AVR underwent preoperative cardiovascular magnetic resonance (CMR) with T1 mapping and echocardiography with global longitudinal strain (GLS) analysis. Collagen volume fraction (CVF) was measured in myocardial biopsies (71) sampled at the time of AVR. The 12-lead ECG was performed preoperatively and 3 and 12 months postoperatively. Results. ECG strain-positive patients (prevalence of 43.4%) had more severe AS, increased LV mass, higher levels of brain natriuretic peptides (BNP) and high-sensitivity troponin I, lower GLS, and lower LV ejection fraction (LVEF). Patients with ECG strain had more diffuse fibrosis, as evident by higher native T1 values (974.8 ± 33.6 ms vs 946.5 ± 28.2 ms, p < 0.001). ECG strain was the only predictor of increased LV mass index on multivariate regression analysis (OR = 7.10, 95% CI 1.46–34.48, p = 0.015). Patients with persistent ECG strain at 1 year following AVR had larger LV volumes and mass, lower GLS, lower LVEF, higher BNP levels, and more histological fibrosis (CVF 12.5% vs. 7.3%, p = 0.009) at baseline assessment. Conclusion. ECG strain is a marker of adverse structural and functional LV remodeling and interstitial myocardial fibrosis. Lack of improvement in ECG strain following AVR indicates more advanced baseline LV injury and higher levels of myocardial fibrosis.
- 29 December 2022
- Published by Vilnius University Press
Structural myocardial changes in patients with severe aortic valve stenosis and their clinical implications
Miokardo struktūrinių pokyčių nustatymas ir jų klinikinės reikšmės įvertinimas pacientams, sergantiems didelio laipsnio aortos vožtuvo angos stenoze
- 29 December 2022
- Published by Vilnius University Press
Structural myocardial changes in patients with severe aortic valve stenosis and their clinical implications
Miokardo struktūrinių pokyčių nustatymas ir jų klinikinės reikšmės įvertinimas pacientams, sergantiems didelio laipsnio aortos vožtuvo angos stenoze
- 3 March 2022
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 38 (7) , 1555-1568
Exploring myocardial fibrosis in severe aortic stenosis: echo, CMR and histology data from FIB-AS study
Myocardial fibrosis in aortic stenosis is associated with worse survival following aortic valve replacement. We assessed myocardial fibrosis in severe AS patients, integrating echocardiographic, cardiovascular magnetic resonance (CMR) and histological data. A total of 83 severe AS patients (age 66.4 ± 8.3, 42% male) who were scheduled for surgical AVR underwent CMR with late gadolinium enhancement and T1 mapping and global longitudinal strain analysis. Collagen volume fraction was measured in myocardial biopsies (71) that were sampled at the time of AVR. Results. CVF correlated with imaging and serum biomarkers of LV systolic dysfunction and left side chamber enlargement and was higher in the sub-endocardium compared with midmyocardium (pp=0.040]. GLS was associated with invasively (CVF; r=−0.303, p=0.013) and non-invasively (native T1; r=−0.321, p<0.05) measured myocardial fibrosis. GLS and native T1 correlated with parameters of adverse LV remodelling, systolic and diastolic dysfunction and serum biomarkers of heart failure and myocardial injury. Conclusion. Our data highlight the role of myocardial fibrosis in adverse cardiac remodelling in AS. GLS has potential as a surrogate marker of myocardial fibrosis, and high native T1 and low GLS values differentiated patients with more advanced cardiac remodelling.
- 3 March 2022
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 38 (7) , 1555-1568
Exploring myocardial fibrosis in severe aortic stenosis: echo, CMR and histology data from FIB-AS study
Myocardial fibrosis in aortic stenosis is associated with worse survival following aortic valve replacement. We assessed myocardial fibrosis in severe AS patients, integrating echocardiographic, cardiovascular magnetic resonance (CMR) and histological data. A total of 83 severe AS patients (age 66.4 ± 8.3, 42% male) who were scheduled for surgical AVR underwent CMR with late gadolinium enhancement and T1 mapping and global longitudinal strain analysis. Collagen volume fraction was measured in myocardial biopsies (71) that were sampled at the time of AVR. Results. CVF correlated with imaging and serum biomarkers of LV systolic dysfunction and left side chamber enlargement and was higher in the sub-endocardium compared with midmyocardium (pp=0.040]. GLS was associated with invasively (CVF; r=−0.303, p=0.013) and non-invasively (native T1; r=−0.321, p<0.05) measured myocardial fibrosis. GLS and native T1 correlated with parameters of adverse LV remodelling, systolic and diastolic dysfunction and serum biomarkers of heart failure and myocardial injury. Conclusion. Our data highlight the role of myocardial fibrosis in adverse cardiac remodelling in AS. GLS has potential as a surrogate marker of myocardial fibrosis, and high native T1 and low GLS values differentiated patients with more advanced cardiac remodelling.
- Open Access
- 13 December 2021
- Published by Springer Nature in Research Square
Exploring myocardial fibrosis in severe aortic stenosis: echo, CMR and histology data from FIB-AS study
PurposeMyocardial fibrosis in aortic stenosis (AS) is associated with worse survival following aortic valve replacement (AVR). We assessed myocardial fibrosis in severe AS patients, integrating echocardiographic, cardiovascular magnetic resonance (CMR) and histological data. MethodsA total of 83 severe AS patients (age 66.4 ± 8.3, 42% male) who were scheduled for surgical AVR underwent CMR with late gadolinium enhancement (LGE) and T1 mapping and global longitudinal strain (GLS) analysis. Collagen volume fraction (CVF) was measured in myocardial biopsies (71) that were sampled at the time of AVR. ResultsCVF correlated with imaging and serum biomarkers of LV systolic dysfunction and left side chamber enlargement and was higher in the sub-endocardium compared with midmyocardium (p<0.001). CVF median values were higher in LGE-positive versus LGE-negative patients [28.7% (19-33) vs 20.7% (15-30), respectively, p=0.040]. GLS was associated with invasively (CVF; r=-0.303, p=0.013) and non-invasively (native T1; r=-0.321, p<0.05) measured myocardial fibrosis. GLS and native T1 correlated with parameters of adverse LV remodelling, systolic and diastolic dysfunction and serum biomarkers of heart failure and myocardial injury. ConclusionOur data highlight the role of myocardial fibrosis in adverse cardiac remodelling in AS. GLS has potential as a surrogate marker of myocardial fibrosis, and high native T1 and low GLS values differentiated patients with more advanced cardiac remodelling.
- 13 December 2021
- Published by Springer Nature in Research Square
Open AccessExploring myocardial fibrosis in severe aortic stenosis: echo, CMR and histology data from FIB-AS study
PurposeMyocardial fibrosis in aortic stenosis (AS) is associated with worse survival following aortic valve replacement (AVR). We assessed myocardial fibrosis in severe AS patients, integrating echocardiographic, cardiovascular magnetic resonance (CMR) and histological data. MethodsA total of 83 severe AS patients (age 66.4 ± 8.3, 42% male) who were scheduled for surgical AVR underwent CMR with late gadolinium enhancement (LGE) and T1 mapping and global longitudinal strain (GLS) analysis. Collagen volume fraction (CVF) was measured in myocardial biopsies (71) that were sampled at the time of AVR. ResultsCVF correlated with imaging and serum biomarkers of LV systolic dysfunction and left side chamber enlargement and was higher in the sub-endocardium compared with midmyocardium (p<0.001). CVF median values were higher in LGE-positive versus LGE-negative patients [28.7% (19-33) vs 20.7% (15-30), respectively, p=0.040]. GLS was associated with invasively (CVF; r=-0.303, p=0.013) and non-invasively (native T1; r=-0.321, p<0.05) measured myocardial fibrosis. GLS and native T1 correlated with parameters of adverse LV remodelling, systolic and diastolic dysfunction and serum biomarkers of heart failure and myocardial injury. ConclusionOur data highlight the role of myocardial fibrosis in adverse cardiac remodelling in AS. GLS has potential as a surrogate marker of myocardial fibrosis, and high native T1 and low GLS values differentiated patients with more advanced cardiac remodelling.
- Open Access
- 8 June 2020
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 20 (1) , 1-10
Prognostic value of myocardial fibrosis in severe aortic stenosis: study protocol for a prospective observational multi-center study (FIB-AS)
Background: Adverse cardiac remodeling with a myocardial fibrosis as a key pathophysiologic component may be associated to worse survival in aortic stenosis (AS) patients. Therefore, with the application of advanced cardiac imaging we aim to investigate left ventricular myocardial fibrosis in severe AS patients undergoing aortic valve replacement (AVR) and determine its impact with post-intervention clinical outcomes. Methods: In a prospective, observational, cohort study patients with severe AS scheduled either for surgical or transcatheter AVR will be recruited from two tertiary heart centers in Denmark and Lithuania. All patients will receive standard of care in accordance with the current guidelines and will undergo additional imaging testing before and after AVR: echocardiography with deformation analysis and cardiovascular magnetic resonance (CMR) with T1 parametric mapping. Those undergoing surgical AVR will also have a myocardial biopsy sampled at the time of a surgery for histological validation. Patients will be recruited over a 2-year period and followed up to 2 years to ascertain clinical outcomes. Follow-up CMR will be performed 12 months following AVR, and echocardiography with deformation analysis will be performed 3, 12, and 24 months following AVR. The study primary outcome is a composite of all-cause mortality and major adverse cardiovascular events. Discussion: Despite continuous effort of research community there is still a lack of early predictors of left ventricular decompensation in AS, which could improve patient risk stratification and guide the optimal timing for aortic valve intervention, before irreversible left ventricular damage occurs. Advanced cardiac imaging and CMR derived markers of diffuse myocardial fibrosis could be utilized for this purpose. FIB-AS study is intended to invasively and non-invasively assess diffuse myocardial fibrosis in AS patients and investigate its prognostic significance in post-interventional outcomes. The results of the study will expand the current knowledge of cardiac remodeling in AS and will bring additional data on myocardial fibrosis and its clinical implications following AVR. Ethics/dissemination: The study has full ethical approval and is actively recruiting patients. The results will be disseminated through scientific journals and conference presentations. Trial registration: ClinicalTrials.gov NCT03585933. Registered on 02 July 2018.
- 8 June 2020
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 20 (1) , 1-10
Open AccessPrognostic value of myocardial fibrosis in severe aortic stenosis: study protocol for a prospective observational multi-center study (FIB-AS)
Background: Adverse cardiac remodeling with a myocardial fibrosis as a key pathophysiologic component may be associated to worse survival in aortic stenosis (AS) patients. Therefore, with the application of advanced cardiac imaging we aim to investigate left ventricular myocardial fibrosis in severe AS patients undergoing aortic valve replacement (AVR) and determine its impact with post-intervention clinical outcomes. Methods: In a prospective, observational, cohort study patients with severe AS scheduled either for surgical or transcatheter AVR will be recruited from two tertiary heart centers in Denmark and Lithuania. All patients will receive standard of care in accordance with the current guidelines and will undergo additional imaging testing before and after AVR: echocardiography with deformation analysis and cardiovascular magnetic resonance (CMR) with T1 parametric mapping. Those undergoing surgical AVR will also have a myocardial biopsy sampled at the time of a surgery for histological validation. Patients will be recruited over a 2-year period and followed up to 2 years to ascertain clinical outcomes. Follow-up CMR will be performed 12 months following AVR, and echocardiography with deformation analysis will be performed 3, 12, and 24 months following AVR. The study primary outcome is a composite of all-cause mortality and major adverse cardiovascular events. Discussion: Despite continuous effort of research community there is still a lack of early predictors of left ventricular decompensation in AS, which could improve patient risk stratification and guide the optimal timing for aortic valve intervention, before irreversible left ventricular damage occurs. Advanced cardiac imaging and CMR derived markers of diffuse myocardial fibrosis could be utilized for this purpose. FIB-AS study is intended to invasively and non-invasively assess diffuse myocardial fibrosis in AS patients and investigate its prognostic significance in post-interventional outcomes. The results of the study will expand the current knowledge of cardiac remodeling in AS and will bring additional data on myocardial fibrosis and its clinical implications following AVR. Ethics/dissemination: The study has full ethical approval and is actively recruiting patients. The results will be disseminated through scientific journals and conference presentations. Trial registration: ClinicalTrials.gov NCT03585933. Registered on 02 July 2018.
- 14 April 2020
- Published by Springer Nature in European Radiology
- Vol. 30 (9) , 5222
Correction to: Prevalence and prognostic value of late gadolinium enhancement on CMR in aortic stenosis: meta-analysis
The original version of this article, published on 12 August 2019, unfortunately contained a mistake. The funding note was incorrect; the correct funding n
- 14 April 2020
- Published by Springer Nature in European Radiology
- Vol. 30 (9) , 5222
Correction to: Prevalence and prognostic value of late gadolinium enhancement on CMR in aortic stenosis: meta-analysis
The original version of this article, published on 12 August 2019, unfortunately contained a mistake. The funding note was incorrect; the correct funding n
- Open Access
- 1 March 2020
- Published by Elsevier in Hellenic Journal of Cardiology
- Vol. 61 (2) , 92-98
Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications
- 1 March 2020
- Published by Elsevier in Hellenic Journal of Cardiology
- Vol. 61 (2) , 92-98
Open AccessTransthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications